Press Releases

Rho’s Chief Medical Officer Jack Modell Presenting During 12th Annual CNS Summit

Nov 9, 2021, 16:08 PM by
Rho, a full-service contract research organization (CRO), is showcasing its clinical development expertise during the 12th Annual CNS Summit, taking place at the Encore Boston Harbor Hotel from November 7-10, 2021. Rho’s Chief Medical Officer, Dr. Jack Modell, along with Dr. John Greist and Dr. Thomas Laughren, will present during a Spotlight Session at the Summit. The 50-minute breakout session, titled, “The Seven Essentials of Clinical Development: How to Avoid Shooting Yourself in the Foot” will showcase the speakers’ combined experience in clinical medicine, academic research, regulatory affairs, and development of drugs and medical applications of information technology.

MEDIA ADVISORY

 

Rho’s Chief Medical Officer Jack Modell Presenting During

12th Annual CNS Summit

CRO Expert to Discuss the Seven Essentials of Clinical Development alongside

 Dr. Thomas Laughren, Director of Laughren Psychopharm Consulting and

Dr. John Greist, Chief Medical Officer of MERET Solutions

 

WHAT:            Rho, a full-service contract research organization (CRO), is showcasing its clinical development expertise during the 12th Annual CNS Summit, taking place at the Encore Boston Harbor Hotel from November 7-10, 2021.

 

Rho’s Chief Medical Officer, Dr. Jack Modell, along with Dr. John Greist and Dr. Thomas Laughren, will present during a Spotlight Session at the Summit. The 50-minute breakout session, titled, “The Seven Essentials of Clinical Development:  How to Avoid Shooting Yourself in the Foot” will showcase the speakers’ combined experience in clinical medicine, academic research, regulatory affairs, and development of drugs and medical applications of information technology.

 

Each of these experts have had the privilege of being involved with scores of drug and device trials and clinical development programs. In reflecting on the differences between successful and unsuccessful clinical trials or programs, several factors consistently emerge as essential components of success and failure.  The goal of this session is to remind participants of the details and importance of these essentials so that effective therapies have a greater likelihood of reaching patients in need.

 

WHO:              Jack Modell, M.D., CMO, Rho

John Greist, M.D., CMO, MERET Solutions, LLC

Thomas Laughren, M.D., Director, Laughren Psychopharm Consulting, LLC

 

WHEN:             Monday, November 8, 2:00-2:50pm EST

 

WHERE:           Encore Boston Harbor

1 Broadway, Everett, MA 02149

 

MEDIA CONTACT:      

Kelly Maicon

Largemouth Communications

(919) 741-9784; kmaicon@largemouthpr.com

 

ABOUT:

Rho, a privately held contract research organization (CRO) located in Research Triangle Park, NC, provides a full range of clinical research services across the entire drug development process. For more than 35 years, Rho has been a trusted partner to leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. Please follow us on Facebook, LinkedIn and Twitter.

 

###